CTLA4 抗体
-
- 抗原 See all CTLA4 抗体
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
适用
- 小鼠
-
宿主
-
仓鼠
-
克隆类型
- 单克隆
-
标记
- This CTLA4 antibody is un-conjugated
-
应用范围
- ELISA
- 特异性
- Mouse CD152, Mr 33-37 kDa
- 产品特性
- Hamster Anti-Mouse CD152-LE/AF
- 内毒素水平
- Low endotoxin
- 免疫原
- Heat-killed Staphylococcus A bacteria coated with mouse CTLA-4/human IgG1 fusion protein
- 克隆位点
- 9H10
- 亚型
- IgG
- Top Product
- Discover our top product CTLA4 Primary Antibody
-
-
- 应用备注
-
- Applications: ELISA - Quality tested , FC - Reported in literature , IP - Reported in literature , Costim - Reported in literature , Block - Reported in literature
- Working Dilutions: ELISA Purified (UNLB) antibody 1 g/mL
- 说明
-
In vitro and in vivo blocking of CTLA-4 action by soluble antibody, Promotion of in vitro CTLA-4 signaling by cross-linked antibody
- 样本量
- 1 mL
- 限制
- 仅限研究用
-
- 浓度
- 0.5 mg/mL
- 缓冲液
- 0.5 mg of purified immunoglobulin in 1.0 mL of PBS
- 储存液
- Azide free
- 注意事项
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- 储存条件
- -20 °C
- 储存方法
- Aliquot and freeze the low endotoxin, azide-free product at -20 °C immediately upon receipt.
-
- 抗原
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
- 别名
- CD152 (CTLA4 产品)
- 别名
- CTLA-4 antibody, CTLA4 antibody, CD152 antibody, Cd152 antibody, Ctla-4 antibody, Ly-56 antibody, CD antibody, CELIAC3 antibody, GRD4 antibody, GSE antibody, IDDM12 antibody, sCTLA4 antibody, cytotoxic T-lymphocyte associated protein 4 antibody, cytotoxic T-lymphocyte-associated protein 4 antibody, CTLA4 antibody, Ctla4 antibody
- 背景
- CD152, also known as CTLA-4, is homologous to the costimulatory molecule CD28. Like CD28, the CD152 molecule binds the family of B7 counter-receptors (CD80/B7-1 and CD86/B7-2) on antigen-presenting cells. CTLA-4 is not expressed on resting T lymphocytes but is induced 2-3 days following T-cell stimulation via the T cell receptor (TCR) complex. Whereas CD28 provides a positive costimulatory signal, CD152/CTLA-4 is a negative regulator of T-cell activation, possibly by inhibiting tyrosine kinase signalling through the TCR through its association with tyrosine phosphatases such as SHP-2.
- 途径
- Cancer Immune Checkpoints
-